Will therapy with psychadelic drugs become mainstream?
In The News
00:00
Intro
Exploration of the Compass Pathway Trial using psilocybin to study its therapeutic benefits for treatment-resistant depression, emphasizing the clinical approach and significance contrasted with recreational drug use.
Play episode from 00:00
Transcript
